Series A funding round for Remix Therapeutics raising $65M in December 2020
Series A funding round for Remix Therapeutics raising $65M in December 2020
| Investor | Firm Type | Partner |
|---|
Foresite CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Shane Neman | |
| Angel | Josh Resnick |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$271M
Top Valuation
-
Remix Therapeutics raised $65M in a Series A round.
The round was announced on 12/01/20.
The round was led by Foresite Capital.